Evaluating Aprepitant single-dose plus granisetron and dexamethasone in children receiving highly emetogenic chemotherapy for the prevention of chemotherapy-induced nausea and vomiting: A triple-blinded randomized clinical trial

INTRODUCTION: This study was performed to evaluate the degree of 3-day chemotherapy-induced nausea and vomiting (CINV) in children with cancer who received highly emetogenic chemotherapy (HEC) to ascertain the efficacy of aprepitant single-dose on dayL 1 plus granisetron and dexamethasone (DEX). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Eghbali, Aziz, Kohpar, Fatemeh Khazaei, Ghaffari, Kazem, Afzal, Roghayeh Rahimi, Eghbali, Aygin, Ghasemi, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499563/
https://www.ncbi.nlm.nih.gov/pubmed/35428609
http://dx.doi.org/10.1016/j.htct.2022.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499563/
https://www.ncbi.nlm.nih.gov/pubmed/35428609
http://dx.doi.org/10.1016/j.htct.2022.02.004

Ejemplares similares